CeyHello, a newly launched social networking mobile app, tackles medication adherence by connecting patients, caregivers and family members.
While it's made great strides, the healthcare industry is still behind in some technology and information safeguards.
Part of the challenge for drugmakers, medical-device makers and healthcare providers is finding the right digital talent and advocating for cultural changes within their organizations.
Drug spending projected to grow at 6% clip through 2024, spurred in part by pricey new medications; FDA approves new obesity device; Sanofi diabetes combo drug is better at reducing blood glucose than Lantus.
The health insurer will offer Fit4D's diabetes coaching program to its members after testing the program during a pilot last year.
The government released new data showing how much pharma and device companies spent for research and marketing purposes last year.
The activity monitor dominates the fitness market, but competition in the overall health category is increasing.
Drugmakers engage early with insurers; patients push for implant to be pulled from the market; about one-third of new drugs qualify for special approval pathways
The manufacturer's SynchroMed drug-infusion pump was associated with 14 deaths.
Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech
- When it comes to professional ads, print makes its comeback
- Amgen takes issue with yet-to-be published multiple-myeloma drug report
- Following positive outcomes data, a new diabetes class is on the rise
- How Watson for Oncology is advancing cancer care
- Creative partners should push pharma clients to tell better stories